Rochester Medical Announces New Opportunity in the United Kingdom

FemSoft(R) Insert for female stress urinary incontinence has been approved for
reimbursement by the United Kingdom's National Health Service.

STEWARTVILLE, Minn., Sept. 21 /PRNewswire-FirstCall/ -- Rochester Medical
Corporation (Nasdaq: ROCM) today announced that the Company's FemSoft(R)
Insert has been approved for inclusion in Part IX of the UK Drug Tariff as a
prescription product which is reimbursable.

There are no other products listed in the Drug Tariff specifically for
managing female stress urinary incontinence, and the Company believes that for
many women this will be a very welcome addition that offers a discreet,
non-surgical, odor-free, secure, and safe alternative to absorbents.

FemSoft(R) Inserts are particularly effective in situations where leakage
occurs during certain physical activities such as exercise, coughing,
laughing, or sneezing.

Hugh McLeod, General Manager of the U.K. business commented that this
represents a significant opportunity for Rochester Medical and will enhance
the Company's position as the leading worldwide innovator and marketer of
silicone continence care devices.

He noted that the FemSoft(R) Insert product line fits perfectly alongside
Rochester Medical's current portfolio of catheters for intermittent
self-catheterization and will be marketed through the same customer base of
Urology Nurse Specialists and Continence Nurse Specialists.

Commenting on the news, Anthony J. Conway Rochester Medical CEO and President
said, "This is excellent news for women in the United Kingdom and also great
news for Rochester Medical. We believe the FemSoft(R) Insert provides an
elegant non-surgical, comfortable, and dry alternative to absorbents. Earlier
this year we announced that U.S. Medicare has given preliminary reimbursement
approval to the FemSoft Insert, and we expect final confirmation in the near
future. In both the U.K. and U.S. we expect implementation of the
reimbursement to begin in January 2010, and we are making sales and marketing
preparations accordingly."

About Rochester Medical

Rochester Medical is the world's leading manufacturer of all-silicone
catheters for urological and continence care applications. Our advanced line
of latex-free products features male external catheters, intermittent
catheters, Foley catheters and urethral inserts as well as latex-free
accessories.

More information about Rochester Medical is available on its website at
http://www.rocm.com.

Forward-Looking Statement
This press release contains "forward-looking statements" that are based on
currently available information, operating plans and management's expectations
about future events and trends. They inherently involve risks and
uncertainties that could cause actual results to differ materially from those
predicted in such forward-looking statements, including the uncertainty of
estimated revenues and profits, the uncertainty of current domestic and
international economic conditions that could adversely affect the level of
demand for the Company's products and increased volatility in foreign exchange
rates, the uncertainty of market acceptance of new product introductions, the
uncertainty of gaining new strategic relationships or locating and
capitalizing on strategic opportunities, the uncertainty of timing of private
label sales revenues (particularly international customers), FDA and other
regulatory review and response times, and other risk factors listed from time
to time in the Company's SEC reports and filings, including, without
limitation, the section entitled "Risk Factors" in the Company's Annual Report
on Form 10-K for the year ended September 30, 2008 and subsequent reports on
Forms 10-Q and 8-K. Readers are cautioned not to place undue reliance on any
such forward-looking statements, which speak only as of the date they are
made. The Company undertakes no obligation to update any forward-looking
statements, whether as a result of new information, future events or
otherwise.

Contact: Anthony J. Conway
President and Chief Executive Officer
Rochester Medical Corporation
Phone: (507) 533-9600

SOURCE Rochester Medical Corporation

Anthony J. Conway, President and Chief Executive Officer of Rochester Medical
Corporation, +1-507-533-9600